- Country: USA
- Summary: Adolescent Overdose Prevention and Sud Treatment Initiative (r21 - Clinical Trial Not Allowed)
- UST Ref No: 93062549
- Deadline: 13 Mar 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-DA-25-030
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- This Funding Opportunity Announcement (Foa) Encourages Exploratory And Developmental Research To Better Understand Adolescent Illicit Fentanyl Use And Overdose Patterns Among Youth At High Risk For Overdose. Research Studies Should Identify Targets For Overdose Prevention And Substance Use Disorder (Sud) Treatment And Recovery. Research Studies May Use A Variety Of Approaches (E.G., Leveraging Existing Data Sources, Survey Research, Social Network Analysis, New Methods Development, Feasibility R...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAdolescent Overdose Prevention and Sud Treatment Initiative (r21 - Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Adolescent Overdose Prevention and Sud Treatment Initiative (r21 - Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 93062549 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-13.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
